A. Dharmadhikari, P. K. Chaurasia, Y. Patel, Deepanshu Choudhary et al.
Introduction Lumateperone, an atypical antipsychotic drug, has a dual mechanism of action by combination of activity at central serotonin (5-HT2A) and dopamine (D2) receptors. Objectives This subgroup analysis of an Indian Phase 3 study was conducted to evaluate the efficacy and safety of Lumatepero...